Romiplostim

Details

Files
Generic Name:
Romiplostim
Project Status:
Complete
Therapeutic Area:
Chronic immune (idiopathic) thrombocytopenic purpura (ITP)
Manufacturer:
Amgen Canada Inc.
Brand Name:
Nplate
Project Line:
Reimbursement Review
Project Number:
SR0179-000
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Chronic immune (idiopathic) thrombocytopenic purpura (ITP)
Recommendation Type:
Do not list
Final Recommendation: